PHGE - BiomX Inc.
0.5353
0.019 3.605%
Share volume: 42,559
Last Updated: 05-12-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.52
0.02
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-14-2024 | 03-25-2025 | |
| Assets | |||
| Total Assets | 59.980 M | 43.233 M | |
| Current Assets | 0.000 | 0.000 | |
| Inventories | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | |
| Current Cash | 23.537 M | 16.856 M | |
| Total Non-current Assets | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 59.980 M | 43.233 M | |
| Total liabilities | 22.084 M | 19.085 M | |
| Total current liabilities | 0.000 | 0.000 | |
| Accounts Payable | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | |
| Total Shareholder equity | 19.251 M | 24.148 M | |
| Common stock | 185.435 M | 186.200 M | |
| Retained earnings | -166.184 M | -180.697 M |
